NCT04905225

Brief Summary

The aim of our study is to analyze the early and late results in men and women who underwent ascending aortic replacement in antegrade cerebral perfusion (ACP) with mild-to-moderate hypothermic circulatory arrest. Female gender is associated with poorer outcomes after surgical aorta replacement. Data on gender specific differences after ascending aortic replacement are conflicting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 27, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

9.4 years

First QC Date

May 23, 2021

Last Update Submit

November 27, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Operative mortality

    Operative mortality (%) as assessed by data linkage to medical records Comparison of men vs women in aortic hemiarch surgery with respect to the incidence of death

    During the first 30 days after the procedure

  • All-cause mortality

    all-cause mortality as assessed by data linkage to medical records or or phone contact with relatives or physicians

    Up to 5 years

Secondary Outcomes (6)

  • Perioperative Myocardial Infarction

    During the first 30 days after the procedure (assessed by daily serum assay and ECG in the ICU and every 5 days after discharge from ICU. )

  • Rates of re-exploration for bleeding

    During the first 3 days after the procedure

  • Respiratory failure

    During the first 30 days after the procedure

  • The duration of a patient's stay in the intensive care unit and on the hospital ward

    Up to 90 days after surgery

  • Incidence of Acute Kidney Injury (AKI)

    During the first 30 days after the procedure

  • +1 more secondary outcomes

Study Arms (1)

Ascending aortic replacement

Ascending aortic replacement in ascending aortic aneurysm in men and women

Procedure: Ascending aortic replacement

Interventions

Surgical access will be performed through a median sternotomy. Ascending aortic repair is performed under conditions of cardiopulmonary bypass (CPB) and MHCA with unilateral ACP via innominate artery with a flow rate of 8-10 ml/kg/min and perfusion pressure of 60-80 mmHg. Once CPB is instituted, the aortic cross-clamp is applied, and the heart is arrested with antegrade cardioplegia. Hemiarch replacement involves resection lesser curve of the aortic arch from the base of the innominate artery (Zone 0) to a point immediately distal to the nadir of the lesser curvature (Zone 3 or Zone 2 if the left subclavian artery was too far).

Ascending aortic replacement

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with ascending aortic aneurysm with Hemiarch replacement

You may qualify if:

  • Patients with small ascending aortic aneurysm (5.0-5.5 cm)
  • Elective procedure
  • Able to provide written informed consent

You may not qualify if:

  • Surgery for acute aortic dissection or emergent operations
  • Refusal of surgical treatment
  • Oncological disease (high degrees)
  • Multiple organ failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tomsk NRMC

Tomsk, 634012, Russia

Location

MeSH Terms

Conditions

Aneurysm, Ascending Aorta

Condition Hierarchy (Ancestors)

Aortic Aneurysm, ThoracicAortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Boris N Kozlov, Dr

    TOMSK NRMC CARDIOLOGY RESEARCH INSTITUTE

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2021

First Posted

May 27, 2021

Study Start

January 1, 2013

Primary Completion

June 1, 2022

Study Completion

July 1, 2023

Last Updated

November 28, 2023

Record last verified: 2023-11

Locations